Jupiter Endovascular, Inc. announced that the full results of the SPIRARE II pivotal trial, evaluating the company’s Vert ...
Haemonetics Corporation announced FDA approval of the PerQseal Elite vascular closure system for large-bore arterial procedures ...
Penumbra, Inc. announced that the FDA has granted clearance for the treatment of deep vein thrombosis (DVT) to the company&rsqu ...
Results from the prospective, single-arm, multicenter POWER PAD II study demonstrated that the Pulse intravascular lithotripsy ...
A secondary analysis of the randomized SirPAD trial demonstrated lower rates of target-lesion revascularization (TLR) and major ...
Six-month results from Esprit BTK PAS were reported in patients with chronic limb-threatening ischemia (CLTI) treated with the ...
At VIVA 2026, the Vascular InterVentional Advances conference, William A. Gray, MD, presented findings from a subgroup analysis ...
One-year results from the prospective, multicenter, single-arm PROMISE III trial evaluated transcatheter arterialization of the ...
A study of computer-assisted vacuum thrombectomy (CAVT) met its predefined primary effectiveness and safety endpoints for the t ...
A post hoc analysis of the randomized HI-PEITHO study examined potential predictors of major bleeding in patients with acute in ...
The ELEGANCE registry, which focuses on historically underrepresented populations to generate real-world evidence, evaluated en ...
The 24-month data from the entire cohort of the SUCCESS PTA study were presented by Thomas Zeller, MD, in a late-breaking clini ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results